Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22

被引:0
作者
John M. Peters
Robert Barnes
Lynda Bennett
William M. Gitomer
Anne M. Bowcock
Abhimanyu Garg
机构
[1] University of Texas Southwestern Medical Center at Dallas,Department of Pediatrics and McDermott Center for Human Growth and Development
[2] University of Texas Southwestern Medical Center at Dallas,Department of Internal Medicine
[3] Center for Human Nutrition,undefined
[4] University of Texas Southwestern Medical Center at Dallas,undefined
[5] Center for Mineral Metabolism,undefined
[6] University of Texas Southwestern Medical Center at Dallas,undefined
来源
Nature Genetics | 1998年 / 18卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Obesity is strongly implicated in the pathophysiology of insulin resistance, diabetes mellitus and dyslipidemia1–3. The mechanisms, however, by which obesity causes these complications are not known. The study of single-gene disorders affecting adipose tissue may elucidate some of the mechanisms involved in these processes. Familial partial lipodystrophy, Dunnigan variety, (FPLD, OMIM 308980) is an autosomal-dominant condition characterized by marked loss of subcutaneous adipose tissue affecting the trunk and extremities but with excess fat deposition in the head and neck areas4–14. Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus, dyslipidemia and acanthosis nigricans4–14. The genetic basis of FPLD is unknown. We carried out a genome-wide scan with a set of highly polymorphic short tandem-repeats (STR) in individuals from five well-characterized pedigrees and mapped the FPLD locus to chromosome 1q21–22. The maximum two-point lod score obtained with a highly polymorphic microsatellite at D1S2624 at θmax=0 was 5.84. Multipoint-linkage analysis yielded a peak lod score of 8.25 between D75305 and D1S1600. There was no evidence for genetic heterogeneity (α=1) in the pedigrees.
引用
收藏
页码:292 / 295
页数:3
相关论文
共 55 条
  • [1] Reaven GM(1988)Role of insulin resistance in human disease Diabetes 37 1595-1607
  • [2] DeFronzo RA(1997)Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerosis Neth. J. Med. 50 191-197
  • [3] Landsberg L(1996)Obesity and the insulin resistance syndrome Hypertens. Res. 19 S51-55
  • [4] Dunnigan MG(1974)Familial lipoatrophic diabetes with dominant transmission: a new syndrome Q. J. Med. 49 33-48
  • [5] Cochrane MA(1975)Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipoatrophic diabetes Humangenetik 29 111-120
  • [6] Kelly A(1986)Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state J. Med. Genet 23 120-127
  • [7] Scott JW(1975)Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities Diabetologia 11 561-568
  • [8] Kobberling J(1981)Partielle Lipodystrophie mit lipatrophischem Diabetes und Hyperlipoproteinamie Verh. Dtsch. Ges. Inn. Med. 87 958-961
  • [9] Willms B(1986)Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome) J. Med. Genet. 23 128-130
  • [10] Kattermann R(1982)Familial partial lipodystrophy: complications of obesity in the non-obese? Metabolism 31 445-452